Cargando…

Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820567/ https://www.ncbi.nlm.nih.gov/pubmed/31695435 http://dx.doi.org/10.2147/OTT.S235000

Ejemplares similares

Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer
por: Shen, Danyang, et al.
Publicado: (2019)

A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours
por: Yen, W-C, et al.
Publicado: (2006)

Corrigendum to “GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)”
Publicado: (2022)

Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
por: Shimizu, Masahito, et al.
Publicado: (2008)

Corrigendum to: “Farnesoid X receptor (FXR): Structures and ligands” [Comput. Struct. Biotechnol. J. 19 (2021) 2148–2159]
por: Jiang, Longying, et al.
Publicado: (2022)

An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene
por: Jurutka, Peter W., et al.
Publicado: (2022)

Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
Publicado: (2021)

Corrigendum to “Synergistic Effects of Toxic Elements on Heat Shock Proteins”
por: Mahmood, Khalid, et al.
Publicado: (2015)

Corrigendum to “Docetaxel-Induced Systemic Sclerosis with Internal Organ Involvement Masquerading as Congestive Heart Failure”
por: Park, Bumsoo, et al.
Publicado: (2017)

Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression
por: Hu, Linyi, et al.
Publicado: (2019)

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]
Publicado: (2019)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]
Publicado: (2022)

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003
por: Clarke, N.W., et al.
Publicado: (2020)

Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells [Corrigendum]
Publicado: (2023)

Corrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”
por: Huang, Suning, et al.
Publicado: (2020)

Of Retinoids and Organotins: The Evolution of the Retinoid X Receptor in Metazoa
por: Fonseca, Elza, et al.
Publicado: (2020)

Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARγ/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats
por: Zuo, Yuchun, et al.
Publicado: (2019)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]
Publicado: (2021)

Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum]
Publicado: (2019)

Corrigendum to: FGFR/Heartless and Smog interact synergistically to negatively regulate Fog mediated G-protein coupled receptor signaling in the Drosophila nervous system
por: Shweta, Kumari, et al.
Publicado: (2021)

Retinoid X Receptor Antagonists
por: Watanabe, Masaki, et al.
Publicado: (2018)

Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer [Corrigendum]
Publicado: (2023)

Corrigendum to: The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
Publicado: (2020)

Corrigendum to ‘New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells’
por: Lee, Soo Ok, et al.
Publicado: (2020)

The Retinoid and Non-Retinoid Ligands of the Rod Visual G Protein-Coupled Receptor
por: Ortega, Joseph T., et al.
Publicado: (2019)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

Construction of High Loading Natural Active Substances Nanoplatform and Application in Synergistic Tumor Therapy [Corrigendum]
Publicado: (2022)

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer
por: Gil, Eun Young, et al.
Publicado: (2017)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
Publicado: (2019)

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum]
Publicado: (2022)

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2023)

Corrigendum to “Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate”
por: Rabe, Thomas, et al.
Publicado: (2018)

A Prospective Study on the Efficacy of Cognitive Targeted Transrectal Ultrasound Prostate Biopsy in Diagnosing Clinically Significant Prostate Cancer [Corrigendum]
Publicado: (2021)

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”
por: Quintanal-Villalonga, A., et al.
Publicado: (2018)

Corrigendum to Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine
Publicado: (2019)

Corrigendum: Acknowledgments. Effect of Photoselective Vaporization Prostatectomy on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia With or Without Intravesical Prostatic Protrusion
por: Kim, Myung Soo, et al.
Publicado: (2013)

Corrigendum to “An Efficient CNN for Hand X-Ray Classification of Rheumatoid Arthritis”
por: Mate, Gitanjali S., et al.
Publicado: (2021)

Retinoic Acid and Retinoid X Receptors
por: Schubert, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6n566qj0coqe2prprga81cnkp2